News

Policy & Practice


 

von Eschenbach to Head FDA

Andrew C. von Eschenbach, M.D., has been named acting commissioner of the Food and Drug Administration, following the resignation of Lester Crawford, D.V.M., Ph.D. Dr. von Eschenbach served as head of the National Cancer Institute prior to his appointment. “As a practicing physician and research scientist, I share in the critical mission of this agency in protecting and promoting the health of the American people,” he said in a statement. Dr. Crawford had a 30-year career with the agency, serving as its deputy commissioner and director of the Center for Veterinary Medicine, among other posts. “It is time, at the age of 67, to step aside,” he said.

Pages

Recommended Reading

Policy & Practice
MDedge Rheumatology
Commission Begins Struggle to Reform Medicaid
MDedge Rheumatology
Prepare Now for Medicare Part D Launch in January
MDedge Rheumatology
Fed Attempts to Ease EHR Transition, Level Playing Field
MDedge Rheumatology
New Medicare Appeals Process Raises Concerns
MDedge Rheumatology
Hospital Process Measures Improve, JCAHO Finds
MDedge Rheumatology
Physician Panel Challenges Vendor Authority in CAP
MDedge Rheumatology
Policy & Practice
MDedge Rheumatology
NIH Eases Stock Restrictions for Most Employees
MDedge Rheumatology
Local Health Networks Share Electronic Data
MDedge Rheumatology